- Home
- ILMN vs AEE Comparison
ILMN vs AEE Comparison
Compare ILMN & AEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- AEE
- Stock Information
- Founded
- ILMN 1998
- AEE 1901
- Country
- ILMN United States
- AEE United States
- Employees
- ILMN 9300
- AEE N/A
- Industry
- ILMN Medical Specialities
- AEE Power Generation
- Sector
- ILMN Health Care
- AEE Utilities
- Exchange
- ILMN Nasdaq
- AEE Nasdaq
- Market Cap
- ILMN 22.9B
- AEE 25.3B
- IPO Year
- ILMN 2000
- AEE N/A
- Fundamental
- Price
- ILMN $144.15
- AEE $94.39
- Analyst Decision
- ILMN Buy
- AEE Buy
- Analyst Count
- ILMN 20
- AEE 13
- Target Price
- ILMN $160.68
- AEE $85.45
- AVG Volume (30 Days)
- ILMN 2.4M
- AEE 1.6M
- Earning Date
- ILMN 11-04-2024
- AEE 11-06-2024
- Dividend Yield
- ILMN N/A
- AEE 2.84%
- EPS Growth
- ILMN N/A
- AEE N/A
- EPS
- ILMN N/A
- AEE 4.26
- Revenue
- ILMN $4,390,000,000.00
- AEE $7,058,000,000.00
- Revenue This Year
- ILMN N/A
- AEE $5.37
- Revenue Next Year
- ILMN $4.28
- AEE $5.63
- P/E Ratio
- ILMN N/A
- AEE $22.18
- Revenue Growth
- ILMN N/A
- AEE N/A
- 52 Week Low
- ILMN $97.36
- AEE $67.03
- 52 Week High
- ILMN $156.66
- AEE $95.69
- Technical
- Relative Strength Index (RSI)
- ILMN 52.47
- AEE 65.55
- Support Level
- ILMN $140.56
- AEE $93.31
- Resistance Level
- ILMN $146.30
- AEE $95.69
- Average True Range (ATR)
- ILMN 4.65
- AEE 1.44
- MACD
- ILMN 0.05
- AEE 0.26
- Stochastic Oscillator
- ILMN 63.86
- AEE 78.86
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves more than 2.4 million electricity customers and more than 900,000 natural gas customers.